SCHEMBL13495288

SCHEMBL13495288

CON1C(=O)CC1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL784740 0.81
SCHEMBL13495310 0.77 BRD4 (0.40)
SCHEMBL12562612 0.75 MEN1 (0.44)
SCHEMBL13495303 0.73 CRBN (0.39)
SCHEMBL7455351 0.70 MEN1 (0.45)
Succinamide SCHEMBL7647282 0.70 TSHR (0.36)
SCHEMBL5469801 0.69 NOTUM (0.51)
SCHEMBL18084352 0.67 POLB (0.35)
SCHEMBL21389292 0.66
SCHEMBL12089355 0.66

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015004400-A1 NOVEL ANTIBODY-DRUG CONJUGATES AND THE USE OF SAME IN THERAPY UNIVERSITE FRANCOIS RABELAIS (FR) 2015-01-15 WO disclosed
US-8329377-B2 Imide compound and chemically amplified resist composition containing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-12-11 US disclosed
US-20100028807-A1 Imide Compound and Chemically Amplified Resist Composition Containing The Same SUMITOMO CHEMICAL COMPANY, LTD. (JP) 2010-02-04 US disclosed